Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

349 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hyaluronic acid rectal spacer in EBRT: Usability, safety and symmetry related to user experience.
Williams J, Millan KM, Bolton D, Tan A, Cham CW, Pham T, Pan D, Liu M, Chan Y, Manohar P, Thomas J, Koufogiannis G, Ho H, Guerrieri M, Ng M, Boike T, Macleod C, Joon DL, Foroudi F, Chao M. Williams J, et al. Among authors: guerrieri m. J Med Imaging Radiat Sci. 2022 Dec;53(4):640-647. doi: 10.1016/j.jmir.2022.09.008. Epub 2022 Oct 4. J Med Imaging Radiat Sci. 2022. PMID: 36202722 Free article.
Impact of hydrogel and hyaluronic acid rectal spacer on rectal dosimetry and toxicity in low-dose-rate prostate brachytherapy: a multi-institutional analysis of patients' outcomes.
Lin YH, Loon W, Tacey M, Bolton D, Tan A, Chan Y, Cham CW, Ho H, Guerrieri M, Foroudi F, Joon DL, McMillan K, Koufogiannis G, Manohar P, Liu M, Pham T, Chao M. Lin YH, et al. Among authors: guerrieri m. J Contemp Brachytherapy. 2021 Dec;13(6):605-614. doi: 10.5114/jcb.2021.112110. Epub 2021 Dec 30. J Contemp Brachytherapy. 2021. PMID: 35079245 Free PMC article.
High dose rate brachytherapy boost for prostate cancer: Biochemical control and the impact of transurethral resection of the prostate and hydrogel spacer insertion on toxicity outcomes.
Chao M, Bolton D, Lim Joon D, Chan Y, Lawrentschuk N, Ho H, Spencer S, Wasiak J, Guerrieri M, Ow D, Troy A, Pham T, Sengupta S, Tan A, McMillan K, Koufogiannis G, Foroudi F, Ng M, Khoo V. Chao M, et al. Among authors: guerrieri m. J Med Imaging Radiat Oncol. 2019 Jun;63(3):415-421. doi: 10.1111/1754-9485.12882. Epub 2019 Mar 25. J Med Imaging Radiat Oncol. 2019. PMID: 30908894
[No title available]
[No authors listed] [No authors listed] PMID: 34701089
Neoadjuvant radiotherapy for locally advanced and high-risk breast cancer.
Chidley P, Foroudi F, Tacey M, Khor R, Yeh J, Bevington E, Hyett A, Loh SW, Chew G, McCracken J, Neoh D, Yeo B, Baker C, Jassal S, Law M, Zantuck N, Cokelek M, Guerrieri M, Brown B, Stoney D, Ng M, Chao M. Chidley P, et al. Among authors: guerrieri m. J Med Imaging Radiat Oncol. 2021 Jun;65(3):345-353. doi: 10.1111/1754-9485.13180. Epub 2021 Apr 5. J Med Imaging Radiat Oncol. 2021. PMID: 33821576 Review.
Improving rectal dosimetry for patients with intermediate and high-risk prostate cancer undergoing combined high-dose-rate brachytherapy and external beam radiotherapy with hydrogel space.
Chao M, Ow D, Ho H, Chan Y, Joon DL, Spencer S, Lawrentschuk N, Guerrieri M, Pham T, McMillan K, Tan A, Foroudi F, Tang J, Wasiak J, Liu M, Koufogiannis G, Cham CW, Bolton D. Chao M, et al. Among authors: guerrieri m. J Contemp Brachytherapy. 2019 Feb;11(1):8-13. doi: 10.5114/jcb.2019.82836. Epub 2019 Feb 28. J Contemp Brachytherapy. 2019. PMID: 30911304 Free PMC article.
A single institution analysis of low-dose-rate brachytherapy: 5-year reported survival and late toxicity outcomes.
Chao M, Spencer S, Guerrieri M, Ding W, Goharian M, Ho H, Ng M, Healey D, Tan A, Cham C, Joon DL, Lawrentschuk N, Travis D, Sengupta S, Chan Y, Troy A, Pham T, Clarke D, Liodakis P, Bolton D. Chao M, et al. Among authors: guerrieri m. J Contemp Brachytherapy. 2018 Apr;10(2):155-161. doi: 10.5114/jcb.2018.75600. Epub 2018 Apr 30. J Contemp Brachytherapy. 2018. PMID: 29789764 Free PMC article. Review.
349 results